Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 4 1

Status

Completed 7Recruiting 4Unknown 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Classical hematology 7Thoracic 1

Conditions

Neoplasms 10Venous Thromboembolism 7Venous Thrombosis 3Treatment of Venous Thromboembolism in Cancer Patients 3Pulmonary Embolism 3Upper Extremity Deep Vein Thrombosis 2Thrombosis 1Recurrence 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Myeloproliferative Disorders 1Lung Neoplasms 1Hemorrhage 1Carcinoma, Non-Small-Cell Lung 1

Interventions

apixaban 11Dalteparin 10Rivaroxaban 7Enoxaparin 5Fondaparinux 4Tinzaparin 3Heparin, Low-Molecular-Weight 3Aspirin 3edoxaban 2Warfarin 2Observation 2Dabigatran 2sotorasib 1calcium heparin 1betrixaban 1bemiparin 1argatroban 1Tacrolimus 1Tablets 1Simvastatin 1Rosuvastatin Calcium 1Nadroparin 1Heparin 1Gemcitabine 1Drug Therapy 1Data Collection 1Cyclosporine 1AVE 5026 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Venous Thromboembolism × Rivaroxaban × Clear all
NCT06314763 2024-04-30

ROSIE

Radboud University Medical Center

Phase 4 Completed
21 enrolled
Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT05461807 2022-10-26

H2H-OSCAR-US

Bayer

Completed
2,437 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

NCT03965741 2021-11-30

PRACTISE

Bayer

Completed
97,765 enrolled
Classical hematology

Venous Thromboembolism

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Janssen Research & Development, LLC

Phase 3 Completed
841 enrolled 24 charts
Classical hematology

Neoplasms, Venous Thromboembolism

NCT03214172 2018-09-06

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Bayer

Completed
1,000 enrolled
Classical hematology

Venous Thromboembolism

NCT02746185 2018-08-13

CASTA-DIVA

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
159 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡